Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer

• Published in: International journal of molecular sciences 2022-03, Vol.23 (5), p.2811
• Main Authors: Pitolli, Consuelo, Marini, Alberto, Sette, Claudio, Pagliarini, Vittoria
• Format: Article
• Language: English
• Subjects: Adenosine; Alternative Splicing - genetics; back-splicing; Binding sites; Brain - metabolism; Brain cancer; Brain tumors; brain tumours; Catalysis; Central nervous system; chimeric RNAs; Computational neuroscience; Cyclin-dependent kinases; Efficiency; Genes; Genomes; Humans; Introns; Kinases; microexons; Neoplasms - genetics; Phosphorylation; Physiology; Proteins; recursive splicing; Regulation; Review; RNA - genetics; RNA polymerase; RNA Precursors - genetics; RNA processing; RNA Splicing - genetics; RNA-binding proteins; Splicing
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23052811

The advance of experimental and computational techniques has allowed us to highlight the existence of numerous different mechanisms of RNA maturation, which have been so far unknown. Besides canonical splicing, consisting of the removal of introns from pre-mRNA molecules, non-canonical splicing events may occur to further increase the regulatory and coding potential of the human genome. Among these, splicing of microexons, recursive splicing and biogenesis of circular and chimeric RNAs through back-splicing and trans-splicing processes, respectively, all contribute to expanding the repertoire of RNA transcripts with newly acquired regulatory functions. Interestingly, these non-canonical splicing events seem to occur more frequently in the central nervous system, affecting neuronal development and differentiation programs with important implications on brain physiology. Coherently, dysregulation of non-canonical RNA processing events is associated with brain disorders, including brain tumours. Herein, we summarize the current knowledge on molecular and regulatory mechanisms underlying canonical and non-canonical splicing events with particular emphasis on cis-acting elements and trans-acting factors that all together orchestrate splicing catalysis reactions and decisions. Lastly, we review the impact of non-canonical splicing on brain physiology and pathology and how unconventional splicing mechanisms may be targeted or exploited for novel therapeutic strategies in cancer.